Washington, Oct 23 (AP) The US Food and Drug Administration has approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given through an IV for patients needing hospitalization.

The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the US National Institutes of Health.

Also Read | US Presidential Election 2020: Amazon Workers Plan to Shut Down Warehouses on Halloween If They Don’t Get Paid Leave to Vote.

It had been authorized for use on an emergency basis since spring, and now has become the first drug to win full US approval for treating COVID-19.

Gilead says Veklury is approved for people at least 12 years old and weighing at least 40 kilograms who need hospitalization for their coronavirus infection. It works by inhibiting a substance the virus uses to make copies of itself. (AP)

Also Read | Coca-Cola Decides to Discontinue Production of 200 Drink Brands to Focus on Profitable Beverages: Report.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)